Imatinib Completed Phase 2 Trials for Cancers / Leukemia, Other Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00250042A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec